Eurand
This article was originally published in The Tan Sheet
Executive Summary
Drug delivery firm acquired by investment firm E.M. Warburg, Pincus from American Home Products, Eurand says April 15. OTC products made by Eurand include enhanced delivery acetaminophen products as well as taste-masked pseudoephedrine, dextromethorphan and diphenhydramine syrups and soft melt tablets. The firm also has developed an enhanced delivery ranitidine product that is not yet sold in the U.S.; the launch may begin in about 18 months. Warner-Lambert markets OTC Zantac 75 ranitidine stomach acid blocker; private label ranitidine is expected to reach the market June 19. AHP acquired Eurand as part of its acquisition of A.H. Robins in 1989. Warburg, Pincus has holdings in several Rx drug and device firms
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning